An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy

NCT00993226 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: SABER-Bupivacaine Treatment 1a
DRUG: Placebo SABER-Bupivacaine Treatment 1b
DRUG: Bupivacaine HCl Treatment 1c
DRUG: SABER-Bupivacaine Treatment 2a
DRUG: Placebo SABER-Bupivacaine Treatment 2b
DRUG: Bupivacaine HCl Treatment 2c

Sponsor

Durect

Collaborators

[object Object]